SCHEMBL13298467

SCHEMBL13298467

c1ccc([SiH2]c2ccc3c(-c4ccc5ccccc5c4)c4ccccc4c(-c4ccncc4)c3c2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPK10 P53779 10/20 0.42
▸ MAPK9 P45984 9/20 0.42
▸ MAPK8 P45983 3/20 0.42
▸ HSD17B1 P14061 1/20 0.37
▸ HSD17B2 P37059 1/20 0.37
▸ CYP17A1 P05093 1/20 0.36
▸ CYP19A1 P11511 1/20 0.36
▸ CYP11B1 P15538 1/20 0.36
▸ CYP11B2 P19099 1/20 0.36
▸ MAPK14 Q16539 2/20 0.36
▸ CSNK1D P48730 1/20 0.36
▸ MAPK11 Q15759 1/20 0.36
▸ ESR1 P03372 2/20 0.35
▸ ESR2 Q92731 2/20 0.35
▸ CCNC P24863 1/20 0.35
▸ CDK8 P49336 1/20 0.35
▸ CHEK1 O14757 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13298469 1.00 MAPK10 (0.42) MAPK10MAPK9MAPK8HSD17B1HSD17B2
SCHEMBL13298463 0.91 ESR1 (0.40) HSD17B1HSD17B2CYP17A1CYP19A1CYP11B1
SCHEMBL13298459 0.91 ESR1 (0.40) HSD17B1HSD17B2CYP17A1CYP19A1CYP11B1
SCHEMBL13298490 0.89 ESR1 (0.39) HSD17B1HSD17B2CYP17A1CYP19A1CYP11B1
SCHEMBL13298515 0.89 ESR1 (0.40) HSD17B1HSD17B2CYP17A1CYP19A1CYP11B1
SCHEMBL13298507 0.89 ESR1 (0.40) HSD17B1HSD17B2CYP17A1CYP19A1CYP11B1
SCHEMBL13298474 0.89 IMPDH2 (0.41) HSD17B1HSD17B2MAPK14ESR1ESR2
SCHEMBL13298462 0.88 NOTUM (0.42) HSD17B1HSD17B2CYP19A1MAPK14ESR1
SCHEMBL13298473 0.88 NOTUM (0.42) HSD17B1HSD17B2CYP19A1MAPK14ESR1
SCHEMBL13298550 0.85 HSD17B1 (0.41) HSD17B1HSD17B2CYP17A1CYP19A1CYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same DONGJIN SEMICHEM CO., LTD (KR) 2010-06-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100133996-A1 Novel anthracene typed compound and the organic electroluminescence display device using the same TRPA1, TRPM2, TRPM4 MAPK10 1447/4885MAPK9 1262/4885MAPK8 1334/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback